BioNTech SE Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$2.07 | -$0.70 | -$1.25 |
| Q2 2024 | 6 | -$3.35 | -$1.14 | -$2.02 |
| Q3 2024 | 4 | -$2.53 | -$0.86 | -$1.53 |
| Q4 2024 | 11 | -$0.42 | $2.42 | $0.64 |
| Q1 2025 | 3 | -$3.05 | -$1.03 | -$1.84 |
| Q2 2025 | 2 | -$3.71 | -$1.26 | -$2.24 |
| Q3 2025 | 2 | -$0.27 | -$0.09 | -$0.16 |
| Q4 2025 | 2 | $0.10 | $0.30 | $0.18 |
BioNTech SE Earnings Date And Information
BioNTech SE last posted its earnings results on Monday, November 4th, 2024. The company reported $0.89 earnings per share for the quarter, topping analysts' consensus estimates of $-1.26 by $2.15. The company had revenue of 128.70 M for the quarter and had revenue of 3.82 B for the year. BioNTech SE has generated $4 earnings per share over the last year ($3.83 diluted earnings per share) and currently has a price-to-earnings ratio of -50.35. BioNTech SE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
BioNTech SE Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2024 | Q2 2024 | -$2.16 | -$3.36 | -1.2 | $144.58 M | $128.70 M |
| 05/06/2024 | Q1 2024 | -$0.82 | -$1.31 | -0.49 | $187.60 M | |
| 11/06/2023 | Q4 2023 | -$0.11 | $1.88 | 1.99 | $1.48 B | |
| 08/07/2023 | Q3 2023 | -$0.75 | $0.69 | 1.44 | $899.06 M | $895.30 M |
| 05/08/2023 | Q2 2023 | $0.15 | -$0.79 | -0.94 | $685.12 M | $167.70 M |
| 05/08/2023 | Q1 2023 | $0.15 | $2.05 | 1.9 | $1.28 B | |
| 11/07/2022 | Q4 2022 | $4.61 | $8.94 | 4.33 | $4.28 B | |
| 11/07/2022 | Q3 2022 | $4.61 | $6.98 | 2.37 | $2.02 B | $3.46 B |
| 05/09/2022 | Q2 2022 | $9.65 | $6.45 | -3.2 | $4.07 B | $3.20 B |
| 03/30/2022 | Q1 2022 | $8.23 | $14.24 | 6.01 | $6.37 B | |
| 11/09/2021 | Q4 2021 | $12.62 | $12.98 | 0.36 | $5.53 B | |
| 08/09/2021 | Q3 2021 | $8.91 | $13.14 | 4.23 | $5.90 B | $6.09 B |
| 05/10/2021 | Q2 2021 | $3.74 | $11.42 | 7.68 | $3.86 B | $5.31 B |
| 03/30/2021 | Q1 2021 | -$0.18 | $4.64 | 4.82 | $2.05 B | |
| 11/10/2020 | Q4 2020 | -$0.46 | $1.56 | 2.02 | $345.44 M | |
| 08/11/2020 | Q3 2020 | -$0.29 | -$0.88 | -0.59 | $60.40 M | $67.46 M |
| 03/31/2020 | Q2 2020 | -$0.19 | -$0.38 | -0.19 | $95.00 M | $41.76 M |
| 03/31/2020 | Q1 2020 | -$0.19 | -$0.24 | -0.05 | $27.66 M | |
| 03/31/2020 | Q4 2019 | -$0.19 | -$0.28 | -0.09 | $27.99 M | |
| 09/30/2019 | Q3 2019 | -$0.13 | $34.04 M | $28.66 M |
BioNTech SE Earnings: Frequently Asked Questions
-
When is BioNTech SE's earnings date?
BioNTech SE has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based off last year's report dates.
-
Did BioNTech SE beat their earnings estimates last quarter?
In the previous quarter, BioNTech SE (:BNTX) reported $0.89 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.26 by $2.15.
-
How can I listen to BioNTech SE's earnings conference call?
The conference call for BioNTech SE's latest earnings report can be listened to online.
-
How can I read BioNTech SE's conference call transcript?
The conference call transcript for BioNTech SE's latest earnings report can be read online.
-
How much revenue does BioNTech SE generate each year?
BioNTech SE (:BNTX) has a recorded annual revenue of $3.82 B.
-
How much profit does BioNTech SE generate each year?
BioNTech SE (:BNTX) has a recorded net income of $3.82 B. BioNTech SE has generated $3.83 earnings per share over the last four quarters.
-
What is BioNTech SE's price-to-earnings ratio?
BioNTech SE (:BNTX) has a price-to-earnings ratio of -50.35 and price/earnings-to-growth ratio is 0.09.
